Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05039424 · ClinicalTrials.gov registry record · NA

Endoscopic Myotomy of the Pylorus To Improve Emptying and Symptoms Trial

A NA study of Gastroparesis, sponsored by Matthew Allemang.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05039424 is a NA study of Gastroparesis that is active but no longer recruiting, run by Matthew Allemang. The registered enrollment target is 100 participants, below the 300-participant average among 44 other Gastroparesis trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05039424, a NA study of Gastroparesis, is active but no longer recruiting, sponsored by Matthew Allemang.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

A randomized clinical trial comparing endoscopic per-oral pyloromyotomy (POP) versus a control sham intervention (diagnostic esophagogastroduodenoscopy (EGD) without pyloric disruption) in patients with medically refractory gastroparesis.

Conditions Studied

Interventions

  • PROCEDURE Endoscopic per-oral pyloromyotomy (POP)
  • PROCEDURE Diagnostic esophagogastroduodenoscopy (EGD) without pyloric disruption

Study Locations (1)

Ohio

  • Cleveland Clinic Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-02-23
Est. Completion 2026-07
Phase NA

Sponsor

Matthew Allemang

2 total trials

What the Registry Record Tells You About NCT05039424

The ClinicalTrials.gov registry entry for NCT05039424 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 300-participant average among 44 other Gastroparesis trials with a reported enrollment target (67% lower). The listed sponsor is Matthew Allemang, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastroparesis appearing as the primary indexed condition, and to 2 interventions - of which Endoscopic per-oral pyloromyotomy (POP) is the first listed.

NCT05039424 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05039424 about?

NCT05039424 is a clinical study titled "Endoscopic Myotomy of the Pylorus To Improve Emptying and Symptoms Trial". A randomized clinical trial comparing endoscopic per-oral pyloromyotomy (POP) versus a control sham intervention (diagnostic esophagogastroduodenoscopy (EGD) without pyloric disruption) in patients with medically refractory gastroparesis.

What is the current status of trial NCT05039424?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-02-23. Estimated completion is 2026-07.

What conditions does trial NCT05039424 study?

This clinical trial studies the following conditions: Gastroparesis.

What interventions are being tested in trial NCT05039424?

The interventions under investigation include: Endoscopic per-oral pyloromyotomy (POP) (PROCEDURE), Diagnostic esophagogastroduodenoscopy (EGD) without pyloric disruption (PROCEDURE).

Who is sponsoring clinical trial NCT05039424?

This trial is sponsored by Matthew Allemang, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05039424 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroparesis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.